|
Volumn 107, Issue 2, 2007, Pages 58-60
|
[Vinpotropile in the treatment of cerebral vascular diseases].
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
NOOTROPIC AGENT;
PIRACETAM;
VASODILATOR AGENT;
VINCA ALKALOID;
VINPOCETINE;
ADULT;
ARTICLE;
BLOOD FLOW VELOCITY;
BRAIN CIRCULATION;
CEREBROVASCULAR DISEASE;
COMPARATIVE STUDY;
DOPPLER ECHOGRAPHY;
DOSE RESPONSE;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HUMAN;
IMPEDANCE PLETHYSMOGRAPHY;
MALE;
MIDDLE AGED;
NUCLEAR MAGNETIC RESONANCE IMAGING;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
BLOOD FLOW VELOCITY;
CALCIUM CHANNEL BLOCKERS;
CEREBROVASCULAR CIRCULATION;
CEREBROVASCULAR DISORDERS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG COMBINATIONS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
MIDDLE AGED;
NOOTROPIC AGENTS;
PIRACETAM;
PLETHYSMOGRAPHY, IMPEDANCE;
TREATMENT OUTCOME;
ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;
VASODILATOR AGENTS;
VINCA ALKALOIDS;
|
EID: 79958266358
PISSN: 19977298
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|